{"name":"Evgen Pharma","slug":"evgen-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sulforadex","genericName":"Sulforadex","slug":"sulforadex","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Sulforadex","genericName":"Sulforadex","slug":"sulforadex","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxONW5WWndwWWxROFMxRHpLTFJ0WGxCR1VmTUpGLXFNZVoyM3pqUkU2ZnJrWlM2eURmUkVYQ1p1SkE3WXl2RzlCMURYdWdDTVNEYm51TVpnemNRTmJYUUdQVTFibWVHcy1KdUZNYTRTajRTenUtWDEwR0NLMGZwTTBmLVQtbWNPaXdSM3VBVkluTGthSFpXVVJ1MlhJN2JKbXNMbEV5ZTJQV1dDSy1VcEh4bGluNTg5c2xFUGh5MmF3cVBXMG92c1lMUndzbjhNVXNWYXYwNWh2NFNEME5ZN2wySEg4cVg1dWNja2JJOHFlREdhQQ?oc=5","date":"2023-10-26","type":"pipeline","source":"Proactive Investors","summary":"Proactive news headlines: Poolbeg, Future Metals, EvGen Pharma, Bloomsbury, Cornish and more - Proactive Investors","headline":"Proactive news headlines: Poolbeg, Future Metals, EvGen Pharma, Bloomsbury, Cornish and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPQWhRNkJzeEc4SF9YWXRibnlmU3RlNGd1V2drRFhBb3R3b01QdFBPaGlHU1RvR1RybFhkU21iX2QyMUVlX3JrbWhRUUduZmpjWFhVZHhnV2F5WlcyZlVHM04zT2RDeDZWcVB6MnRKQkEwYXJOOUpja05uMGRIaTNHeEpXSUZpempYbEI3dEkzcG9nRlVjcldJ?oc=5","date":"2023-09-18","type":"trial","source":"Oncology Pipeline","summary":"Bayer looks to clinical validation for $1.5bn Vividion deal | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Bayer looks to clinical validation for $1.5bn Vividion deal | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPSTZidW9VWjdacFpreS1QZGhOM1Bzdlhjcjhzaks3eHZId3Y2aXRHUDNTTVBkdnRyRzZmMGNUcTN5US1NaXJITG5zWU9GclUzZUhTM0JPckNNR1llUzhjNWpzSzNQNS1qaF9vTjFzQkdtamxmM0J6RTdjU1FNa2MycFZETlhoekRMeFQ3ZExEYU1DQ213Y3pDMHoxOFVtaEVOQ0dHMnJsM2pIZWEtQS1NakJxUV9uR29GLWtwNDF5blI5bVRwMWw1Q19BX2NxUnRtUkp0czlQakRLQ0plcy15XzV1M0gwTHZHZ3k0?oc=5","date":"2023-07-19","type":"pipeline","source":"Proactive financial news","summary":"Evgen Pharma CMO highlights \"very aggressive\" disease on Glioblastoma Awareness Day - Proactive financial news","headline":"Evgen Pharma CMO highlights \"very aggressive\" disease on Glioblastoma Awareness Day","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNYzZDUkFXcVpyMFNMMTh4clZWdVdnckFLb1hqYVZBZGdIbVpGU0l4UUg0U2xpTWxyd3FsWEtjUi0zUjk0LVZsd2QzeGowRHlmZUw1a0l2S3Qya0pJNEpaX0FMS19qSzBVZkV6aXNjWUZfZV9aMkcyOGp6bkRHQk5vNFAyVUFVaFNmZnpmWlBpSnBCZw?oc=5","date":"2022-11-16","type":"pipeline","source":"PharmaTimes","summary":"Evgen to investigate new SFX-01 tablet formulation - PharmaTimes","headline":"Evgen to investigate new SFX-01 tablet formulation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQWmdrX1U4V3I2T3M4MXN5cGZVQUZNUDNSR3VGU1Y1a0h2ZjdNZklleFo2WndmdDVtMEdmWkJQcjZNWnl1ODFLT21Yak9WdktQcUdFTzdpRVM0VWRNWjFna0NjdHJXQl85N0diRnF0T2o0dHFaUjBRTHo1REJvYmRBQ2hRd0c1TXJ3YlFUNzJ2SUV0cnZEcExOQ2w4clotSlIzQXk3UnViUzY1ajI2V1hGc2Y3dnRRb1k1MjZJd1V1aGFoem5vbVBtMHhsRXpRNC1oUjYydUw4VGY4T0ItZnVqVjNR?oc=5","date":"2022-10-12","type":"deal","source":"Proactive financial news","summary":"Evgen Pharma signs partnership deal with Stalicla for autism treatment research - Proactive financial news","headline":"Evgen Pharma signs partnership deal with Stalicla for autism treatment research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOZXFoUm1ZN01faTZsRDY1OW5ISEE2MVQtVU5yNDA0aVlaNzBOY1Z5OVJ0UUl3eUwzdXFSN29XWUtYVVJlSXBMT3JvZ1BLZFVHSFNRWkNkMW92ZzRZUHY2ZC1MS0lPZGhOMWNja1FvYXJZOVY5R3dmMnNSdGN5QU9BanJ2TQ?oc=5","date":"2022-10-11","type":"deal","source":"Pharmaceutical Technology","summary":"Stalicla signs licence deal for Evgen Pharma’s lead asset SFX-01 - Pharmaceutical Technology","headline":"Stalicla signs licence deal for Evgen Pharma’s lead asset SFX-01","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNSG1JRm9UNE1NczhLN3k4eVFIM0NsZjVLcDJ3cndlQTJGanhad3hjQTFuU3MtRUFiR1MzUFo5YWtGc0FScWoxSzJfeTJsLXBYNGZZd05EYUszY1FQNGxUa2ZxOXY3SV8wQUhld2tldmhyY3E1SXY0NmY1cmxqM3dQSTBZRm1HWW9ELThfQ1k4enRycnVwVk9GZHpsU2RNNnlHcWI1ME1OTFZfTUVkVEIwYk5FY053M0pUaTQtNEFLX0FHcjhO?oc=5","date":"2022-10-11","type":"pipeline","source":"Startupticker.ch","summary":"STALICLA strengthens pipeline to advance precision medicine for Autism Spectrum Disorders - Startupticker.ch","headline":"STALICLA strengthens pipeline to advance precision medicine for Autism Spectrum Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEtpd0dFQ2NCd0k3SmEyNWEyd3k4SGMwTlNaV19SU3FFVE5ORjBOYlpLQlJId1lwSHpKRExzNTN2bjl2RTQ0ckRzS01GckkyWkJaVUE0dVk4S1JFbDFtZnlRR1dQLW5xRFpOQV9QTFktcndzTTE1aHNXZmUxRlZOdGhLQlZSSTdrUWdsZGNoZHBpazh5?oc=5","date":"2022-09-29","type":"regulatory","source":"PharmaTimes","summary":"Regulatory approval received for Evgen’s SFX-01 study - PharmaTimes","headline":"Regulatory approval received for Evgen’s SFX-01 study","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQRnJaRy1Id3JVOXJlOTZsVEU0QTdJUUhTUHcwRzdNajFtM1hGWG8yNXM4dE9SNlFOV0stZnpmLWEtaHdSc0dacEtQdmhrQnZ0ZXcyWUluLWJzZFhycXhLTjlua3lGRjJMU0Q4ZVhLRVBtbkFxX1NwWnptckstV2M2N1FYblBfY2xQOHBUWmNQOWZ6MTMwVFJVM21QRVZpR1NKTXZfY1U5OVY1SWZVaGQ4?oc=5","date":"2020-04-30","type":"pipeline","source":"thebusinessdesk.com","summary":"North West pharma CEO stands down with immediate effect - thebusinessdesk.com","headline":"North West pharma CEO stands down with immediate effect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOVU5aW1uelhtS1lGS1g0UmQzbGduTk5RQTctbXB5akc0aEpyNFFMQ3pjSmhPU1daVzZCSGZOM1hzdzg0MWFNQVpLV0NxV1hkbmFFYVl4aTNjMlVVQnlwZ25wRjRoRFFyWlItY2V5QmMtVTN4N3U5MkVZMHRJdzgwY1Y1N3JZbFBvRkdSSUtYQWd4RHhDVDQ3bG54UUEyZDgwdFY5bDVLSWw?oc=5","date":"2016-01-05","type":"pipeline","source":"Technology Networks","summary":"Evgen Pharma Appoints Chief Medical Officer - Technology Networks","headline":"Evgen Pharma Appoints Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNRGVCblZJdkpuOHU5QzZydmR5MWtiMGJMQlNZcnhDenpKQWlwMHRCcE04MV9qU1gtbjlEVW9PVDFHOXhQRnpmdWhMWmFKUlNIT281OFNrMFlFMXlmdWF1LTdNLVBxemtHMHB0TmRaSmd1amRuMmkwQ1JzVXN4MTZ1aVY5U2FpTTkzV0Y0UmprZHFSbE9uVllwYzRRV1RoUQ?oc=5","date":"2016-01-04","type":"pipeline","source":"PMLiVE","summary":"Dr Hamina Patel moves from J&J to Evgen Pharma - PMLiVE","headline":"Dr Hamina Patel moves from J&J to Evgen Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}